Professional Documents
Culture Documents
Premia Research Issue Opens: October 25, 2017 Issue Closes: October 27, 2017 Price Band: ` 247-` 252
This document summarizes a few key points related to the issue and should not be treated as a comprehensive summary. Investors are
requested to refer the Red Herring Prospectus for further details regarding the issue, the issuer company and the risk factors before taking any
Recommendation investment decision. Please note that investment in securities is subject to risks including loss of principal amount and past performance is not
indicative of future performance. Nothing herein constitutes an offer of securities for sale in any jurisdiction where it is unlawful to do so.
Not Rated
This document is not intended to be an advertisement and does not constitute an invitation or form any part of any issue for sale or solicitation
of an offer to subscribe for or purchase any securities and neither this document nor anything contained herein shall form the basis for any
Issue Details contract or commitment whatsoever.
Key Points
Key Risks
IIFL Holdings Limited and India Infoline Limited (part of the India Infoline Group) are involved in the initial public offering of Reliance Nippon Life Asset Management Limited,
in the capacity of a Book Running Lead Manager and a Syndicate Member to the Issue. However IIFL Holdings Limited and India Infoline Limited shall not be in any way
responsible for the contents hereof, any omission therefrom or shall be liable for any loss whatsoever arising from use of this document or otherwise arising in connection
therewith, including with respect to forward looking statements, if any. Neither IIFL Holdings Limited nor India Infoline Limited or any of its affiliates, group companies,
directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including lost revenue or lost profits that may
arise from or in connection with the use of the information.
Please refer to http://www.indiainfoline.com/research/disclaimer for recommendation parameter, analyst disclaimer and other disclosures.
Published in 2017. © India Infoline Ltd 2017, India Infoline Limited (Formerly “India Infoline Distribution Company Limited”), CIN No.: U99999MH1996PLC132983, Corporate
Office – IIFL Centre, Kamala City, Senapati Bapat Marg, Lower Parel, Mumbai – 400013 Tel: (91-22) 4249 9000 .Fax: (91-22) 40609049, Regd. Office – IIFL House, Sun Infotech
Park, Road No. 16V, Plot No. B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane – 400604 Tel: (91-22) 25806650. Fax: (91-22) 25806654 E-mail: mail@iifl.com Website:
www.indiainfoline.com, Refer www.indiainfoline.com for detail of Associates.
National Stock Exchange of India Ltd. SEBI Regn. No.: INB231097537/ INF231097537/ INE231097537, Bombay Stock Exchange Ltd. SEBI Regn. No.: INB011097533/
INF011097533/ BSE-Currency, MCX Stock Exchange Ltd. SEBI Regn. No.: INB261097530/ INF261097530/ INE261097537, United Stock Exchange Ltd. SEBI Regn. No.:
INE271097532, PMS SEBI Regn. No. INP000002213, IA SEBI Regn. No. INA000000623, SEBI RA Regn.:- INH000000248.
For Sales and Account related information, write to customer care: cs@iifl.com or call on 91-22 4007 1000